Eagle Eye Opener: Ford Braces for $2 Billion Loss in Europe; Fed Chairman Plans Bond Buying into 2014; Pfizer Forecasts Big 2013 Profit

Eagle Eye Opener

When Better Isn’t Good Enough (Reuters)

Ford (F) earned 31 cents a share in Q4 2012, crushing analysts’ estimates by almost 25 percent. However, investors shouldn’t confuse this optimistic figure with the perception that things are rosy worldwide for the United States’ second-largest auto maker. In fact, Ford lost $1.75 billion last year in Europe — based on the region’s economic woes. And its management doesn’t foresee the situation over there getting a whole lot better in 2013 when the company expects to lose $2 billion. So, if you’re playing Ford this year, realize domestic opportunity is going to drive the company’s profits.

Bernanke Buying Blitz to Top $1.14 Trillion by 2014 (Bloomberg)

U.S. Federal Reserve Chairman Ben Bernanke announced that the government’s latest round of bond buying won’t be finished until it reaches $1.14 trillion — sometime in the first quarter of 2014. So, investors can look forward to Uncle Sam gobbling up $40 billion worth of mortgage bonds and $45 billion of Treasures each month throughout the year — and minimal inflation during that time. The question now becomes, what happens in 2014, when the Bernanke’s buying blitz ends?

Picked the Wrong Year to Stop ‘Doing’ Drugs (Bloomberg)

The world’s largest drug maker, Pfizer, Inc. (PFE), is forecasting profit of $2.30 a share for 2013 — topping the consensus estimate of 19 analysts. The puppies and rainbows forecast is based upon the expectation that two new drugs hitting the market this year each will generate $1 billion in sales. This situation, combined with CEO Ian Read’s overall plan to divest the company of non-drug units and buy back shares, powered the company to a 26 percent profit in the preceding 12 months — not bad for a company with a $197 billion market cap. Investors may want to start “doing” drugs as an investment in 2013.

Exclusive  S&P 500 Declines on Fed Silence; U.S. Dollar Soars on Strong Data; Economy Gained Momentum in Second Quarter

Like This Article?
Now Get Mark's FREE Special Report:
3 Dividend Plays with Sky-High Returns

This newly-released report by a top-20 living economist details three investments that are your best bets for income and appreciation for the rest of the year and beyond.

Get Access to the Report, 100% FREE


img
previous article

Last week featured a plethora of information as nearly 500 companies reported not only their December quarter results but issued their near-term outlook. It was a smorgasbord of data with views that were positive, negative and, in some cases, conflicting.

PREMIUM SERVICES FOR INVESTORS

Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details

LEARN MORE HERE

Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details

LEARN MORE HERE

Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details

LEARN MORE HERE

Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details

LEARN MORE HERE

Mike Turner

Mike Turner’s financial, mathematical, computer science and engineering background serves as the foundation for his disciplined, rules-based approach to trading. Mike’s three services include:

Product Details

LEARN MORE HERE

Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:

Product Details

LEARN MORE HERE

DividendInvestor.com

Used by financial advisors and individual investors all over the world, DividendInvestor.com is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.

LEARN MORE HERE